{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:08:58Z","timestamp":1792523338066,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF19OC0054908"],"award-info":[{"award-number":["NNF19OC0054908"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF22SA0079901"],"award-info":[{"award-number":["NNF22SA0079901"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015223","name":"Danish Diabetes and Endocrine Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Limited data exist on the bleeding risk associated with concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) and individual direct oral anticoagulants. We investigated the bleeding risks of NSAID use in patients with atrial fibrillation (AF) who were receiving all available oral anticoagulants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This nationwide cohort study included 114 119 patients with first-time diagnosed AF who initiated oral anticoagulation during 2012-22. Time-dependent multivariate cause-specific Cox regression assessed the association between NSAID use and hospital-diagnosed bleeding episodes, calculating adjusted hazard ratios (aHRs). Rates of hospital-diagnosed bleeding events per 100 person-years were 6.2 with NSAID use vs. 3.9 without (number needed to harm = 43 patients treated for 1 year). Compared with non-use, NSAID use was associated with increased rates of hospital-diagnosed bleeding overall [aHR, 1.81; 95% confidence interval (CI), 1.59-2.06], gastrointestinal bleeding (aHR, 2.30; 95% CI, 1.92-2.76), thoracic\/respiratory tract bleeding (aHR, 1.59; 95% CI, 1.13-2.24), urinary tract bleeding (aHR, 1.48; 95% CI, 1.17-1.88), and anaemia caused by bleeding (aHR, 3.50; 95% CI, 2.33-5.26). NSAID use increased bleeding rates across all anticoagulants: rivaroxaban (aHR, 2.05; 95% CI, 1.64-2.57), apixaban (aHR, 2.15; 95% CI, 1.70-2.72), dabigatran (aHR, 1.40; 95% CI, 0.92-2.13), edoxaban (aHR, 2.87; 95% CI, 1.26-6.53), and warfarin (aHR, 1.46; 95% CI, 1.07-1.98). Results were consistent across NSAID subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NSAID use was associated with a nearly two-fold increase in hospital-diagnosed bleeding among patients with AF receiving oral anticoagulation. The risk appeared highest with edoxaban, followed by apixaban and rivaroxaban, and lowest with dabigatran and warfarin. The risk was not restricted to the gastrointestinal tract.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcaf076","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T11:42:32Z","timestamp":1754134952000},"page":"1340-1350","source":"Crossref","is-referenced-by-count":9,"title":["Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-0561","authenticated-orcid":false,"given":"S\u00f8ren Riis","family":"Petersen","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Olof Palmes All\u00e9 43\u201345, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University , Palle Juul-Jensens Boulevard 82, 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8626-2372","authenticated-orcid":false,"given":"Kasper","family":"Bonnesen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Olof Palmes All\u00e9 43\u201345, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University , Palle Juul-Jensens Boulevard 82, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Cardiology, G\u00f8dstrup Regional Hospital, 7400 Herning ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Brogaard","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University , Palle Juul-Jensens Boulevard 82, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-3888","authenticated-orcid":false,"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Olof Palmes All\u00e9 43\u201345, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University , Palle Juul-Jensens Boulevard 82, 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-4059","authenticated-orcid":false,"given":"Morten","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Olof Palmes All\u00e9 43\u201345, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University , Palle Juul-Jensens Boulevard 82, 8200 Aarhus N ,","place":["Denmark"]},{"name":"Department of Cardiology, G\u00f8dstrup Regional Hospital, 7400 Herning ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2025121818530049800_qcaf076-B1","doi-asserted-by":"publisher","first-page":"e077209","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"2025121818530049800_qcaf076-B2","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2025121818530049800_qcaf076-B3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/s0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2025121818530049800_qcaf076-B4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ehjcvp\/pvaa073","article-title":"Prescriber responsibility, predictors for initiation, and 20-year trends in use of non-aspirin non-steroidal anti-inflammatory drugs in patients with cardiovascular contraindications: a nationwide cohort study","volume":"7","author":"Schmidt","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025121818530049800_qcaf076-B5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Coxib and Traditional NSAID Trialists' (CNT) Collaboration","year":"2013","journal-title":"Lancet"},{"key":"2025121818530049800_qcaf076-B6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2025121818530049800_qcaf076-B7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2025121818530049800_qcaf076-B8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/circulationaha.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"key":"2025121818530049800_qcaf076-B9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jacc.2018.04.063","article-title":"Concomitant oral anticoagulant and nonsteroidal anti-inflammatory drug therapy in patients with atrial fibrillation","volume":"72","author":"Kent","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025121818530049800_qcaf076-B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/circulationaha.119.041296","article-title":"Patients with atrial fibrillation taking nonsteroidal anti-inflammatory drugs and oral anticoagulants in the ARISTOTLE trial","volume":"141","author":"Dalgaard","year":"2020","journal-title":"Circulation"},{"key":"2025121818530049800_qcaf076-B11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ehjcvp\/pvz069","article-title":"Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study","volume":"6","author":"Olsen","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025121818530049800_qcaf076-B12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3349\/ymj.2020.61.9.741","article-title":"Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med J"},{"key":"2025121818530049800_qcaf076-B13","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11739-023-03375-9","article-title":"Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study","volume":"18","author":"Catalani","year":"2023","journal-title":"Intern Emerg Med"},{"key":"2025121818530049800_qcaf076-B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10557-023-07521-5","article-title":"Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study","volume":"39","author":"Grymonprez","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025121818530049800_qcaf076-B15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/clep.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2025121818530049800_qcaf076-B17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/clep.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B18","doi-asserted-by":"publisher","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"2025121818530049800_qcaf076-B19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2025121818530049800_qcaf076-B20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"2025121818530049800_qcaf076-B21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/pds.3881","article-title":"The potential drug-drug interaction between proton pump inhibitors and warfarin","volume":"24","author":"Henriksen","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025121818530049800_qcaf076-B22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/eurheartj\/ehae736","article-title":"Bleeding risk using non-steroidal anti-inflammatory drugs with anticoagulants after venous thromboembolism: a nationwide Danish study","volume":"46","author":"Petersen","year":"2025","journal-title":"Eur Heart J"},{"key":"2025121818530049800_qcaf076-B23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/clep.S311450","article-title":"The validity of Danish prescription data to measure use of aspirin and other non-steroidal anti-inflammatory drugs and quantification of bias due to non-prescription drug use","volume":"13","author":"Gaster","year":"2021","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/clep.S37188","article-title":"Positive predictive value of the International Classification of Diseases, 10th edition diagnosis codes for anemia caused by bleeding in the Danish National Registry of Patients","volume":"4","author":"Zalfani","year":"2012","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/clep.S400834","article-title":"Positive predictive value of non-traumatic bleeding diagnoses in the Danish National Patient Register","volume":"15","author":"Thaarup","year":"2023","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/clep.S245060","article-title":"Existing data sources in clinical epidemiology: laboratory information system databases in Denmark","volume":"12","author":"Arendt","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2025121818530049800_qcaf076-B28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/clep.S448347","article-title":"Validity of prescription-defined and hospital-diagnosed hypertension compared with self-reported hypertension in Denmark","volume":"16","author":"Bonnesen","year":"2024","journal-title":"Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2025121818530049800_qcaf076-B30","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/jama.2024.4970","article-title":"Accounting for competing risks in clinical research","volume":"331","author":"Austin","year":"2024","journal-title":"JAMA"},{"key":"2025121818530049800_qcaf076-B31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jclinepi.2009.07.001","article-title":"Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length","volume":"63","author":"Gardarsdottir","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2025121818530049800_qcaf076-B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/14017431.2012.673728","article-title":"Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry","volume":"46","author":"Rix","year":"2012","journal-title":"Scand Cardiovasc J"},{"key":"2025121818530049800_qcaf076-B33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2025121818530049800_qcaf076-B34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/m13-1581","article-title":"Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study","volume":"161","author":"Lamberts","year":"2014","journal-title":"Ann Intern Med"},{"key":"2025121818530049800_qcaf076-B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-5-5","article-title":"Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure","volume":"5","author":"Essebag","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2025121818530049800_qcaf076-B36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.amjmed.2022.05.031","article-title":"Association of antisecretory drugs with upper gastrointestinal bleeding in patients using oral anticoagulants: a systematic review and meta-analysis","volume":"135","author":"Kurlander","year":"2022","journal-title":"Am J Med"},{"key":"2025121818530049800_qcaf076-B37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s2468-1253(18)30037-2","article-title":"Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials","volume":"3","author":"Scally","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121818530049800_qcaf076-B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ehjqcco\/qcad019","article-title":"Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study","volume":"10","author":"Grymonprez","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025121818530049800_qcaf076-B39","first-page":"326","article-title":"Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040","volume":"11","author":"Camacho","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025121818530049800_qcaf076-B40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ehjqcco\/qcae045","article-title":"The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis","volume":"10","author":"Kefale","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025121818530049800_qcaf076-B41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/circulationaha.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"2025121818530049800_qcaf076-B42","doi-asserted-by":"publisher","first-page":"e077880","DOI":"10.1136\/bmj-2023-077880","article-title":"Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study","volume":"386","author":"Camacho","year":"2024","journal-title":"BMJ"},{"key":"2025121818530049800_qcaf076-B43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3346\/jkms.2010.25.3.337","article-title":"Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting","volume":"25","author":"Choi","year":"2010","journal-title":"J Korean Med Sci"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcaf076\/63954617\/qcaf076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/11\/8\/1340\/63954617\/qcaf076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/11\/8\/1340\/63954617\/qcaf076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T23:53:09Z","timestamp":1766101989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/11\/8\/1340\/8222343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,12,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcaf076","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,5]]}}}